Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | XDH | P47989 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 3/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | HES1 | Q14469 | 2/20 | 1.00 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | KDM1A | O60341 | 1/20 | 1.00 |
| ▸ | PRSS1 | P07477 | 1/20 | 1.00 |
| ▸ | PRSS2 | P07478 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | HMGB1 | P09429 | 1/20 | 1.00 |
| ▸ | CFTR | P13569 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | PRSS3 | P35030 | 1/20 | 1.00 |
| ▸ | BACE1 | P56817 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rutin SCHEMBL14369486 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL23244 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL796642 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL20576343 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL2017898 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21424757 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL23663918 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21013017 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21325433 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT | |
| Rutin SCHEMBL21699244 | 1.00 | KDM4E (1.00) | KDM4EXDHMAOAEPHX2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170266153-A1 | COMPOSITIONS PURPOSEFULLY SELECTED COMPRISING PURIFIED CANNABINOIDS AND/OR PURIFIED TERPENES | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2017-09-21 | — | — | US | disclosed |
| US-9713624-B1 | Synthesis of rutin nanotubes | KING SAUD UNIVERSITY (SA) | 2017-07-25 | — | — | US | disclosed |
| US-9441146-B2 | Process for extracting materials from biological material | UNIVERSITEIT LEIDEN (NL) | 2016-09-13 | — | — | US | disclosed |
| US-20160250270-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL | CANOPY GROWTH CORPORATION (CA) | 2016-09-01 | — | — | US | disclosed |
| US-9370541-B2 | Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same | LABORATOIRES EXPANSCIENCE (FR) | 2016-06-21 | — | — | US | disclosed |
| US-20150368283-A1 | D-FAGOMINE FOR THE CONTROL OF INFLAMMATORY PROCESSES RELATED TO AN OVERACTIVATION OF THE HUMORAL IMMUNE RESPONSE | PUMAROLA SEGURA, SERGIO (ES) | 2015-12-24 | — | — | US | disclosed |
| US-20140341934-A1 | PROCESS FOR EXTRACTING MATERIALS FROM BIOLOGICAL MATERIAL | UNIV LEIDEN (NL) | 2014-11-20 | — | — | US | disclosed |
| WO-2014125013-A1 | D-FAGOMINE FOR THE CONTROL OF INFLAMMATORY PROCESSES RELATED TO AN OVERACTIVATION OF THE HUMORAL IMMUNE RESPONSE | BIOGLANE, S.L.N.E. (ES) | 2014-08-21 | — | — | WO | disclosed |
| EP-2767284-A1 | D-Fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response | Bioglane, S.L. (ES) | 2014-08-20 | — | — | EP | disclosed |
| US-20130171082-A1 | EXTRACT OF THE ABOVE-GROUND PORTIONS OF GYNANDROPSIS GYNANDRA OR CLEOME GYNANDRA, AND COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS INCLUDING SAME | LABORATOIRES EXPANSCIENCE (FR) | 2013-07-04 | — | — | US | disclosed |
| US-20130149322-A1 | PROCESS FOR EXTRACTING MATERIALS FROM BIOLOGICAL MATERIAL | UNIVERSITEIT LEIDEN (NL) | 2013-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368283-A1 | D-FAGOMINE FOR THE CONTROL OF INFLAMMATORY PROCESSES RELATED TO AN OVERACTIVATION OF THE HUMORAL IMMUNE RESPONSE | TLR5, CD74, FCGR1A | KDM4E 4876/4885XDH 1788/4885MAOA 195/4885 |
| US-20160250270-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PURIFIED CANNABINOIDS, WITH AT LEAST ONE FLAVONOID, TERPENE, OR MINERAL | CNR2, CNR1, MAG | KDM4E 505/4885XDH 3778/4885MAOA 762/4885 |
| US-20130171082-A1 | EXTRACT OF THE ABOVE-GROUND PORTIONS OF GYNANDROPSIS GYNANDRA OR CLEOME GYNANDRA, AND COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS INCLUDING SAME | CUTA, GLA, LHCGR | KDM4E 1996/4885XDH 1636/4885MAOA 1186/4885 |
| US-20170266153-A1 | COMPOSITIONS PURPOSEFULLY SELECTED COMPRISING PURIFIED CANNABINOIDS AND/OR PURIFIED TERPENES | CNR2, CNR1, FAAH | KDM4E 943/4885XDH 4711/4885MAOA 3650/4885 |
| US-20140341934-A1 | PROCESS FOR EXTRACTING MATERIALS FROM BIOLOGICAL MATERIAL | BMP2, BMP4, BMP6 | KDM4E 2745/4885XDH 2807/4885MAOA 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.